 The study found that antiviral treatments were effective in reducing the risk of hospital admission and mortality from COVID-19. The authors concluded that the prescription of antivirals should be carefully scrutinized by double opinion, not only to contain health care costs, but also to reduce the risk of generating resistant SARS-CoV-2 strains. This article was authored by Luca Segalin, Riccardo Pol, Omar Simonetti, and others.